Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples